Tools

LEADER 02316cam 2200493 a 4500

001 ocm46343789;

003 OCoLC;

005 20141208175400.0;

006 m d f ;

007 cr an- ;

008 010228s2000 dcu sb f000 0 eng c;

035 a| (Sirsi) o46343789;

035 a| (OCoLC)46343789;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D-01 (online);

086 0 a| GA 1.5/2:T-NSIAD-00-140;

100 1 a| Cooper, David E.,d| 1948-=| ^A423334;

245 10 a| Contract management :b| DOD's anthrax vaccine manufacturer will continue to need financial assistance : statement of David E. Cooper, associate director, Defense Acquisitions Issues, National Security and International Affairs Division, before the Subcommittee on Personnel, Committee on Armed Services, U.S. Senate /c| United States General Accounting Office.;

246 30 a| DOD's anthrax vaccine manufacturer will continue to need financial assistance;

260 a| [Washington, D.C.] :b| The Office,c| [2000];

336 a| text2| rdacontent;

337 a| computer2| rdamedia;

338 a| online resource2| rdacarrier;

490 1 a| Testimony ;v| GAO/T-NSIAD-00-140;

500 a| Title from title screen.;

500 a| "April 14, 2000.";

500 a| Paper version available from the General Accounting Office.;

504 a| Includes bibliographical references.;

538 a| System requirements: Adobe Acrobat Reader required.;

538 a| Mode of access: Internet via the GPO Access web site. Address as of 2/16/01: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:ns00140t.pdf; current access is available via PURL.;

610 10 a| United States.b| Department of Defensex| Procurement.=| ^A634641;

610 20 a| Anthrax Vaccine Immunization Program (U.S.)=| ^A423717;

610 20 a| BioPort Corporation.=| ^A455133;

650 0 a| Defense contractsz| United States.=| ^A21552;

710 1 a| United States.b| General Accounting Office.=| ^A1924;

830 0 a| Testimonyv| GAO/T-NSIAD-00-140.=| ^A682308;

856 40 u| https://purl.fdlp.gov/GPO/LPS9752;

998 a| 794759;

998 a| u794759;

596 a| 1;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| MQ1432269d| 8/7/2007l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 4/16/2001x| EDOCUMENTz| JERESOURCEo| .STAFF. 0;

Contract management : DOD's anthrax vaccine manufacturer will continue to need financial assistance : statement of David E. Cooper, associate director, Defense Acquisitions Issues, National Security and International Affairs Division, before the Subcommittee on Personnel, Committee on Armed Services, U.S. Senate / United States General Accounting Office.

Author/creator	Cooper, David E., 1948-
Other author	United States. General Accounting Office.
Format	Electronic
Publication Info	[Washington, D.C.] : The Office, [2000]
Supplemental Content	https://purl.fdlp.gov/GPO/LPS9752
Subjects	United States. Department of Defense--Procurement. Anthrax Vaccine Immunization Program (U.S.) BioPort Corporation. Defense contracts--United States.

Portion of title	DOD's anthrax vaccine manufacturer will continue to need financial assistance
Series	Testimony ; GAO/T-NSIAD-00-140 Testimony GAO/T-NSIAD-00-140. ^A682308
General note	Title from title screen.
General note	"April 14, 2000."
General note	Paper version available from the General Accounting Office.
Bibliography note	Includes bibliographical references.
Technical details	System requirements: Adobe Acrobat Reader required.
Technical details	Mode of access: Internet via the GPO Access web site. Address as of 2/16/01: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:ns00140t.pdf; current access is available via PURL.
GPO item number	0546-D-01 (online)
Govt. docs number	GA 1.5/2:T-NSIAD-00-140

Click here for more information about this title